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summary
Medically unexplained symptoms are considered ‘somatoform disorders’ in the fourth edition of the Diagnos-
tic and Statistical Manual of Mental Disorders (DSM-IV). The introduction of this nosographic category has 
been helpful in drawing attention to a previously neglected area, but has not been successful in promoting an 
understanding of the disorders’ biological basis and treatment implications, probably because of a series of 
diagnostic shortcomings. 
The newly proposed DSM-V diagnostic criteria try to overcome the limitations of the DSM-IV definition, 
which was organised centrally around the concept of medically unexplained symptoms, by emphasising the 
extent to which a patient’s thoughts, feelings and behaviours concerning their somatic symptoms are dispropor-
tionate or excessive. This change is supported by a growing body of evidence showing that psychological and 
behavioural features play a major role in causing patient disability and maintaining high level of health care use. 
Pain disorders is the sub-category of DSM-IV somatoform disorders that most closely resembles fibromyalgia. 
Regardless of the diagnostic changes recently brought about by DSM-V, neuroimaging studies have identified 
important components of the mental processes associated with a DSM- IV diagnosis of pain disorder.
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n	 INTRODUCTION
More than 80% of the general popula-tion report somatic symptoms that 
are not attributable to a clearly defined 
medical condition during the previous 
seven days (1). These findings indicate that 
somatic symptoms are ubiquitous and do 
not per se justify a diagnosis, especially a 
diagnosis of mental disorder. However, a 
subgroup of the people reporting somatic 
symptoms have long-lasting complaints, 
make considerable use of healthcare ser-
vices, and appear to be seriously disabled, 
thus making it necessary to find other fac-
tors for identifying them.
n	 SOMATOFORM DISORDERS  
 FROM DSM-III TO DSM-IV-TR
The disorders characterised by medically 
unexplained symptoms lie in an indefinite 
area between medicine (which classifies 
them as functional somatic syndromes) and 
psychiatry (2) which, from the third edition 
of Diagnostic and Statistical Manual of 
Mental Disorders (DSM III) (3) published 
in 1980, classified as them as somatoform 
disorders. In clinical practice, only a few 
patients with somatic complaints are ex-
amined by a psychiatrist; the majority are 
seen by a general practitioner or by a spe-
cialist who treats the symptom or function 
that leads to the distress. It is known that 
somatic symptoms not explained by a gen-
eral medical condition account for almost 
half of the complaints reported by patients 
seeking primary and secondary care (4). 
The introduction of somatoform disorders 
as a diagnostic category represented an 
advance in clinical psychiatry because it 
replaced the previous ambiguous nosology 
based on diagnostically unreliable with 
a more precise and systematic classifica-
tion. However, although this has been very 
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helpful in drawing attention to a previously 
neglected area, it has not been success-
ful in promoting an understanding of the 
disorders’ biological basis and treatment, 
probably because of a series of shortcom-
ings in the category itself and its specific 
sub-categories (5).
The diagnostic category of somatoform 
disorders has been considered speculative; 
ambiguous in its stated exclusion of general 
medical conditions; imprecise because of 
its overlaps with other psychiatric disorders 
such as depression and anxiety whose di-
agnostic definitions include somatic symp-
toms (5); and scarcely compatible with, or 
even unacceptable to many oriental cultures 
that do not share the West’s dualistic view 
of mind and body (as suggested by its ex-
clusion from the current DSM-based Chi-
nese classification of mental diseases) (6). 
The specific diagnostic sub-categories 
formulated in the Diagnostic and Statisti-
cal Manual of Mental Disorders-IV - Text 
Revision (DSM-IV-TR) (7) include a 
heterogeneous group of disorders united 
solely by their presentation with somatic 
symptoms (Tab. I). The main shortcoming 
of these sub-categories is that their consid-
erable diagnostic overlaps make them con-
fusing and of little clinical use, particularly 
in the non-psychiatric general medical set-
tings primarily attended by such patients 
(8). It is not surprising that more than 90% 
of physicians report an overlap between 
somatisation disorder, pain disorder, hypo-
chondriasis, and “somatoform disorder not 
otherwise specified” (9).
For patients with multiple medically unex-
plained symptoms, the DSM suggests a di-
agnosis of somatisation disorder (the core 
sub-category of somatoform disorders) 
that is based on the number of unexplained 
medical symptoms, and requires four pain, 
two gastrointestinal, one sexual and one 
“pseudo-neurological” symptom. These 
criteria have been criticised as being too 
restrictive because they cover only a very 
small proportion (0.1%) of subjects in the 
general population reporting multiple so-
matic symptoms requiring medical atten-
tion (10%) (10).
The “undifferentiated somatoform disor-
der” (USD) sub-category describes a set 
of unexplained physical symptoms that 
do not cross the threshold of somatisation 
disorder, but the diagnostic criteria were so 
vaguely defined that they would be met by 
a large percentage of the general population 
(a reported primary prevalence of 27%) 
(11). Somatisation disorder not otherwise 
specified is kept as a residual category.
This finding supported the need to reduce 
the number of somatic complaints required 
for a diagnosis of somatisation disorder 
(12). As temporal stability is one of the val-
idation criteria of a psychiatric syndrome 
diagnosis, the hypothesis of reducing the 
number of somatic symptoms is supported 
by the evidence that spontaneous remis-
sion rates are high if patients report only 
one non- pain physical symptom whereas, 
in the presence of at least two somatic 
symptoms (or even one in the case of a pain 
symptom) (13), the syndrome seems to be 
stable over time (14).
Moreover, the classification of multiple so-
matic complaints as DSM mental disorders 
should consider integrating empirically de-
rived psychological and behavioural char-
acteristics with the formal diagnostic crite-
ria (15) as it has been shown that these are 
the main predictors of symptom recurrence 
in chronic pain conditions (16), enable the 
detection of more stable syndromes (17), 
and can help distinguish medically ex-
plained and unexplained syndromes (18). 
Among patients with somatic syndromes, 
psychological factors can distinguish those 
with healthcare needs from those who can 
cope quite well without medical care. They 
can also explain significant aspects of dis-
ability even after controlling for the impact 
Table I - Somatoform disorders: DSM-iv - Tr co-
des and specific diagnostic sub-categories.
300.81 Somatisation disorder
300.81 Undifferentiated somatoform disorder
300.11 Conversion disorder
307.80 Pain disorder
300.7 Hypochondriasis
300.7 Body dysmorphic disorder
300.81 Somatoform disorder not otherwise 
specified
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of somatic symptoms and depression (19).
The most powerful psychological variable 
identifying people with somatic symptoms 
and increased healthcare use and/or serious 
disability is the avoidance of physical activ-
ities that accelerate the heart rate or cause 
sweating. Cognitive variables can also dis-
tinguish the more problematic sub-group 
of people suffering from somatic symp-
toms: catastrophising bodily sensations, 
making attributions to somatic illness, and 
worrying and ruminating about physical 
complaints all contribute to explaining the 
statistical impact of medically unexplained 
somatic symptoms on healthcare use and 
disability (19). A high level of use of health 
services implies excess annual healthcare 
costs that are comparable with those relat-
ed to depression or anxiety disorders (20), 
and requires the development of strategies 
aimed at the early detection of somatising 
patients who might become costly users of 
health services (21).
n	 TOWARD DSM-V
The fifth edition of the Diagnostic and Sta-
tistical Manual of Mental Disorders (DSM-
V) (22) introduces significant changes to 
the diagnostic criteria of somatoform dis-
orders with the aim of eliminating overlaps 
and clarifying boundaries. The novelties of 
the DSM -V are so radical that they impose 
a parallel change in the name somatoform 
disorders to somatic symptom and related 
disorders (SSD). An SSD is characterised 
by one or more somatic symptoms lasting 
for at least six months that are very distress-
ing or lead to significant disruption of func-
tioning, as well as excessive and dispropor-
tionate thoughts, feelings and behaviours 
regarding those symptoms (Tab. II). 
The main changes from the DSM-IV diag-
nosis of somatoform disorders are:
- all of the DSM-IV somatoform disorder 
sub-categories (somatisation disorder, 
pain disorder, undifferentiated somato-
form disorder, hypochondriasis, etc.) 
have been deleted as most of the patients 
previously diagnosed with one of these 
now meet the diagnostic criteria of SSD;
- the SSD diagnosis does not require the 
somatic symptoms to be medically unex-
plained;
- the presence of maladaptive and dispro-
portionate thoughts, feelings, and behav-
iours concerning the somatic symptoms 
becomes the central diagnostic feature of 
SSD, and the somatic symptom count re-
quired by some of the DSM-IV diagnos-
tic categories has been deleted.
DSM-IV was organised centrally around 
the concept of medically unexplained 
symptoms, whereas the DSM-V criteria 
emphasise the extent to which a patient’s 
thoughts, feelings and behaviours regard-
ing their somatic symptoms are dispropor-
tionate or excessive. 
n	 PAIN DISORDER
Pain disorder is the sub-category of DSM-
IV somatoform disorders that most closely 
resembles fibromyalgia. DSM-IV defines 
pain disorder as the occurrence of one or 
more pain symptoms causing significant 
distress or impairment in several areas of 
functioning, with psychological factors 
being judged to play an important role in 
the onset, severity, exacerbation, or main-
tenance of the pain (Tab. III). 
A number of studies have raised concerns 
regarding the validity of the distinction be-
Table II - DSM-v Criteria for somatic symptom di-
sorder.
A. One or more somatic symptoms that are 
distressing or result in significant disruption of daily 
life.
B. excessive thoughts, feelings, behaviours related to 
the somatic symptoms or associated health concerns, 
as manifested by at least one of the following:
1) Disproportionate and persistent thoughts about the 
seriousness of one’s symptoms.
2) Persistently high level of anxiety about health or 
symptoms.
3) excessive time and energy devoted to these 
symptoms or health concerns.
C. Although any one somatic symptom may not be 
continuously present, the state of being symptomatic 
is persistent (typically more than 6 months).
reprinted with permission from the Diagnostic and 
Statistical Manual of Mental Disorders, Fifth edi-
tion, (Copyright© 2013). American Psychiatric As-
sociation. All rights reserved.
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tween pain disorder and pain associated 
with other somatoform disorders made in 
DSM-IV (23). Aigner found a considerable 
overlap of somatoform disorder diagnoses 
in patients who also had a diagnosis of pain 
disorder, with 93% meeting the DSM-IV 
criteria for undifferentiated somatoform 
disorder and 10% meeting the criteria for 
somatisation disorder (24).
In line with these observations, more than 
one-third of surveyed physicians stated that 
the border between the diagnostic criteria 
for pain disorder and somatoform disorder 
not otherwise specified is “unclear” (9).
The perspective change introduced by 
DSM-V has also promoted a different ap-
proach to the disorders characterised by 
pain symptoms that were classified as pain 
disorder in DSM-IV. Evidence showing 
that psychological factors influence all 
types of pain (25) raises doubts about the 
validity and reliability of the distinctions 
between pain associated with psychologi-
cal, medical or traumatic factors.
Most subjects with a DSM-IV diagnosis of 
pain disorder could be appropriately diag-
nosed as having DSM-V somatic symptom 
disorders, whereas others could meet the 
diagnosis of a new mental disorder defined 
as “psychological factors affecting other 
medical conditions”. 
Regardless of the diagnostic changes re-
cently brought about by DSM-V, and de-
spite the doubts regarding the validity of 
the diagnosis, neuroimaging studies have 
identified important components of the 
mental processes associated with a DSM- 
IV diagnosis of pain disorder.
Functional magnetic resonance imaging 
studies have shown that patients with pain 
disrder and controls have different cerebral 
responses to pain stimuli: for example, the 
cerebral processing of noxious heat stim-
uli induces pain-related hypoactivation of 
the ventromedial prefrontal/orbitofrontal 
cortex, and hyperactivation of the parahip-
pocampus, amygdala and anterior insula 
in patients with somatoform pain disorder 
(26). Furthermore, a negative emotional 
context such as sadness the same subjects 
contributes to greater sensitivity to low 
levels of pain probably due to the stronger 
activation of the anterior/posterior insula 
during low-pain stimuli (27). However, 
although neuroimaging studies provide 
information about the involvement of a 
specific neural system in pain disorder, the 
observed differences in neural activation 
between clinical and control groups can-
not be interpreted univocally, but should 
be conceptualised by considering at least 
three different interpretations: as a cause of 
the illness, as an effect of the illness, or as 
compensation for the illness. 
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